Background
Medication discrepancies at care transitions are common and lead to patient harm. Medication reconciliation is a strategy to reduce this risk.
Objectives
To summarize available evidence on medication reconciliation interventions in the hospital setting and identify the most effective practices.
Data Sources
Medline (1966 through February 2012) and hand search of article bibliographies.
Study Selection
26 controlled studies.
Data Extraction
Data were extracted on study design, setting, participants, inclusion/exclusion criteria, intervention components, timing, comparison group, outcomes, and results.
Data Synthesis
Studies were grouped by type of medication reconciliation intervention: pharmacist-related, information technology (IT), or other, and assigned quality ratings utilizing U.S. Preventative Services Task Force criteria.
Results
15 of 26 studies reported on pharmacist-related interventions, 6 evaluated IT interventions, and 5 studied other interventions. 6 studies were classified as good quality. The comparison group for all studies was usual care, with no direct comparisons of different types of interventions. Studies consistently demonstrated a reduction in medication discrepancies (17/17 studies), potential adverse drug events (5/6 studies), and adverse drug events (2/3 studies), but showed inconsistent reduction in post-discharge healthcare utilization (improvement in 2/8 studies). Key aspects of successful interventions included intensive pharmacy staff involvement and targeting the intervention to a ‘high-risk’ patient population.
Conclusions
There is a paucity of rigorously designed studies comparing different inpatient medication reconciliation practices and their effects on clinical outcomes. Available evidence supports medication reconciliation interventions that heavily utilize pharmacy staff and focus on patients at high-risk for adverse events. Higher quality studies are needed to determine the most effective approaches to inpatient medication reconciliation.